Aurobindo Pharma informs about press release

26 Feb 2026 Evaluate
Aurobindo Pharma has enclosed a copy of the Press Release that is being issued by the Company in connection with USFDA approval received by Eugia Pharma Specialities, a wholly owned subsidiary of the Company, for Everolimus Tablets, 0.25 mg, 0.5 mg, 0.75 mg and 1 mg.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1221.55 -0.45 (-0.04%)
27-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1738.10
Dr. Reddys Lab 1287.20
Cipla 1347.65
Zydus Lifesciences 922.50
Lupin 2301.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×